Pfizer Inc. said US regulators (FDA) have approved its cholesterol lowering drug Lipitor.輝瑞公司說，美國監管機構（ FDA ）的批准，其降膽固醇藥物立普妥。 Lipitor is used to reduce the risk of stroke and heart attack in diabetic patients.立普妥是用來降低中風的風險和心髒病發作，在糖尿病患者。

The approval is for patients with type 2, or adult onset, diabetes (NIDDM) who have no signs of heart disease but have multiple risk factors (described below) for the condition.批准，是為病人與2型，或成人斯蒂爾，糖尿病（非胰島素依賴型糖尿病）誰已沒有任何跡象顯示心臟疾病，但有多重危險因素（見下文）為條件。

Common risk factors include high cholesterol, high blood pressure, a family history of heart disease, smoking and obesity.常見的危險因素包括高膽固醇，血壓高的壓力，一個家庭心髒病史，吸煙和肥胖。